Floatz logo

nir178

NSCLC, Non Small Cell Lung Cancer

Novartis PharmaceuticalsPhase 2
Rating in progress

nir178 in NSCLC, Non Small Cell Lung Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Dormant